Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2026-06-29 @ 5:39 AM
Study NCT ID:
NCT05600660
Status:
RECRUITING
Last Update Posted:
2022-11-08
First Post:
2022-10-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Orelabrutinib,Rituximab and Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma
Sponsor:
Organization: